Astrazeneca Plc

AZN chart

Astrazeneca Plc news

• Mohit Manrao Announces AstraZeneca’s New Biomarker Testing Awareness Campaign

  Oncodaily · Nov 9, 1:24 PM EST

• AstraZeneca stock gains new C4XD licence for pipeline programme

  ad-hoc-news.de · Nov 9, 11:35 AM EST

• Global Pharma Giants Vie for Rare Obesity Treatments

  조선일보 · Nov 9, 10:37 AM EST

• What Compugen (CGEN) Said on Its Q3 Earnings Call

  marketbeat.com · Nov 9, 10:14 AM EST

• Gabelli Releases Agenda for 8th Annual Healthcare Symposium

  Yahoo Finance · Nov 9, 8:00 AM EST

• MRK's 2027 Outlook Challenging, Long-Term Prospects Promising

  Yahoo Finance · Nov 9, 7:48 AM EST

• EFN: Could AstraZeneca make a move for Sobi?

  www.lifesciencefocus.com · Nov 9, 7:29 AM EST

• AstraZeneca PLC : Deutsche Bank remains Neutral

  marketscreener.com · Nov 9, 7:08 AM EST

• Compugen Reports Third Quarter 2026 Results

  Yahoo Finance · Nov 9, 7:00 AM EST

• Astrazeneca Pharma India Ltd is Rated Hold

  MarketsMojo · Nov 9, 6:15 AM EST

• Espiria Hållbar Framtid fell 0.1 percent in October, newly invested in AstraZeneca and Systemair

  www.marketscreener.com · Nov 9, 5:53 AM EST

• How Academia and Industry Can Close Hypertension Care Gaps

  AstraZeneca · Nov 9, 5:35 AM EST

Astrazeneca Plc key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KADMISSION OF FURTHER SECURITIES TO TRADING2026-11-02
• 6-KTOTAL VOTING RIGHTS2026-11-02
• 6-K3RD QUARTER RESULTS2026-10-30
• 6-KENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC2026-10-27
• 6-KULTOMIRIS APPROVED IN US IN IGAN2026-10-22
• 6-KASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT2026-10-05
• 6-KAZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY2026-10-02
• 6-KADMISSION OF FURTHER SECURITIES TO TRADING2026-10-01
• 6-KTOTAL VOTING RIGHTS2026-10-01
• 6-KASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT2026-09-29
• 6-KTRIXEO APPROVED IN EU FOR ASTHMA2026-09-23
• 6-KKLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP2026-09-21

About Astrazeneca Plc

Ticker

AZN (NYSE)

Industry

Pharmaceutical Preparations

Headquarters

Cambridge

Incorporated in

United Kingdom

Fiscal year end

December 31

SEC CIK

901832

Former names

ZENECA GROUP PLC

Frequently asked questions